Raised $15M in Seed funding.
The company said the funding supports accelerate commercial growth of its lead biostimulant and nitrogen-fixing seed treatment products worldwide, and fund its commercial launches.
Sector
Every disclosed Biotech & Pharma funding round of $5M or more announced by a US, UK or European company in 2026, with what each company said the money supports.
Latest Moves
The company said the funding supports accelerate commercial growth of its lead biostimulant and nitrogen-fixing seed treatment products worldwide, and fund its commercial launches.
The company said the funding supports the progression of the lead asset, MPT-062, to clinical proof-of-concept and advancement of its broader product pipeline.
The company said the funding supports scale up industrialization with the opening of a dedicated facility in France and grow its B2B foodservice sales model in Europe, Japan, and the United States.
Every round
October 2026 · 10 events · $324M
| Company | Raised | Round | Announced | Source |
|---|---|---|---|---|
| BioConsortia USA | $15M | Seed | 2026-10-12 | announcement |
| Matchpoint Therapeutics USA | $150M | Series B | 2026-10-09 | announcement |
| Edonia France | €15M | Undisclosed | 2026-10-08 | announcement |
| Vinci Pharmaceuticals USA | $8M | Series A | 2026-10-08 | announcement |
| Arboretum LifeSciences USA | $30M | Series A | 2026-10-07 | announcement |
| Sensible Biotechnologies Slovakia | $47M | Undisclosed | 2026-10-06 | announcement |
| WhiteLab Genomics France | $26M | Series B | 2026-10-06 | announcement |
| Consano Bio USA | $15M | Undisclosed | 2026-10-05 | announcement |
| Biotia USA | $9M | Undisclosed | 2026-10-01 | announcement |
| ArkeaBio USA | $7M | Undisclosed | 2026-10-01 | announcement |
September 2026 · 36 events · $2.3B
| Company | Raised | Round | Announced | Source |
|---|---|---|---|---|
| AnaCardio Sweden | €62M | Series B | 2026-09-30 | announcement |
| Astrocyte Pharmaceuticals USA | $10M | Series B | 2026-09-30 | announcement |
| Ray Therapeutics USA | $8M | Grant | 2026-09-30 | announcement |
| ai3Bio USA | $48M | Series A | 2026-09-29 | announcement |
| Aptadir Therapeutics Italy | €40M | Seed | 2026-09-29 | announcement |
| Link Cell Therapies USA | $30M | Series A | 2026-09-29 | announcement |
| BigHat Biosciences USA | $75M | Series C | 2026-09-24 | announcement |
| Kasvu Therapeutics Finland | €30M | Series A | 2026-09-24 | announcement |
| Pilgrim USA | $25M | Seed | 2026-09-24 | announcement |
| Enveda USA | $311M | Series E | 2026-09-23 | announcement |
| Basecamp Research UK | $140M | Series C | 2026-09-23 | announcement |
| Novadip Belgium | €10M | Convertible | 2026-09-21 | announcement |
| Tempo Therapeutics USA | $14M | Undisclosed | 2026-09-18 | announcement |
| Polyphron USA | $20M | Seed | 2026-09-17 | announcement |
| Sling Therapeutics USA | $123M | Series C | 2026-09-16 | announcement |
| Circle Pharma USA | $92M | Series E | 2026-09-16 | announcement |
| Mithrl USA | $20M | Series A | 2026-09-16 | announcement |
| RegCell USA | $66M | Series A | 2026-09-15 | announcement |
| Shennon Biotechnologies USA | $12M | Undisclosed | 2026-09-14 | announcement |
| Ethris Germany | €30M | Undisclosed | 2026-09-11 | announcement |
| Encoded Therapeutics USA | $275M | Series F | 2026-09-09 | announcement |
| Solstice Oncology USA | $225M | Series A | 2026-09-09 | announcement |
| TwoStep Therapeutics USA | $62M | Series A | 2026-09-09 | announcement |
| System USA | $20M | Undisclosed | 2026-09-09 | announcement |
| BrainChild Bio USA | $116M | Series A | 2026-09-08 | announcement |
| Moonwalk Biosciences USA | $70M | Series B | 2026-09-08 | announcement |
| Cloverleaf Bio USA | $33M | Seed | 2026-09-08 | announcement |
| Helogen USA | $7M | Seed | 2026-09-04 | announcement |
| Superluminal Medicines USA | $60M | Series B | 2026-09-03 | announcement |
| Tensive Italy | €20M | Debt | 2026-09-03 | announcement |
| Thyme Care USA | $125M | Series E | 2026-09-02 | announcement |
| Typewriter Therapeutics USA | $56M | Series A | 2026-09-02 | announcement |
| N-Power Medicine USA | $32M | Series B | 2026-09-02 | announcement |
| NovaGo Therapeutics Switzerland | $30M | Series B | 2026-09-02 | announcement |
| Amyl Therapeutics Belgium | €8M | Series A | 2026-09-01 | announcement |
| Senticell USA | $7M | Seed | 2026-09-01 | announcement |
August 2026 · 31 events · $2.0B
| Company | Raised | Round | Announced | Source |
|---|---|---|---|---|
| Adaptyv Biosystems Switzerland | $40M | Series A | 2026-08-31 | announcement |
| EIT Pharma USA | $35M | Series A | 2026-08-31 | announcement |
| Maash Belgium | €12M | Debt | 2026-08-31 | announcement |
| AusperBio USA | $120M | Series C | 2026-08-28 | announcement |
| ProFound Therapeutics USA | $35M | Undisclosed | 2026-08-27 | announcement |
| Airway Therapeutics USA | $50M | Series E | 2026-08-25 | announcement |
| Revier Therapeutics Germany | €6M | Seed | 2026-08-25 | announcement |
| Astromech USA | $20M | Undisclosed | 2026-08-21 | announcement |
| Pixelgen Technologies Sweden | $16M | Series B | 2026-08-20 | announcement |
| PleoPharma USA | $6M | Grant | 2026-08-20 | announcement |
| Network Bio USA | $50M | Undisclosed | 2026-08-19 | announcement |
| KaliVir Immunotherapeutics USA | $14M | Series A | 2026-08-19 | announcement |
| Abcuro USA | $66M | Series D | 2026-08-18 | announcement |
| Leal Therapeutics USA | $30M | Series A | 2026-08-17 | announcement |
| InduPro USA | $77M | Series B | 2026-08-13 | announcement |
| Khartis Therapeutics USA | $50M | Series B | 2026-08-13 | announcement |
| Infinimmune USA | $75M | Series A | 2026-08-12 | announcement |
| Remepy USA | $36M | Series A | 2026-08-12 | announcement |
| Amplifica USA | $26M | Series B | 2026-08-12 | announcement |
| Vaderis Therapeutics Switzerland | $152M | Series B | 2026-08-11 | announcement |
| Aureka Biotechnologies USA | $100M | Series B | 2026-08-11 | announcement |
| Epicrispr Biotechnologies USA | $90M | Series C | 2026-08-11 | announcement |
| Sonablate USA | $200M | Undisclosed | 2026-08-10 | announcement |
| Plantible Foods USA | $35M | Debt | 2026-08-10 | announcement |
| Remedium Bio USA | $10M | Series A | 2026-08-10 | announcement |
| LifeMine Therapeutics USA | $263M | Series E | 2026-08-07 | announcement |
| InsectBiotech Spain | €7M | Undisclosed | 2026-08-06 | announcement |
| Expedition Therapeutics USA | $115M | Series B | 2026-08-05 | announcement |
| Claris Biotherapeutics USA | $118M | Series B | 2026-08-03 | announcement |
| Ratio Therapeutics USA | $70M | Series C | 2026-08-03 | announcement |
| Dash Bio USA | $30M | Series A | 2026-08-03 | announcement |
July 2026 · 21 events · $1.3B
June 2026 · 32 events · $2.4B
| Company | Raised | Round | Announced | Source |
|---|---|---|---|---|
| Lycia Therapeutics USA | $75M | Series D | 2026-06-29 | announcement |
| Ollin Biosciences USA | $330M | Series B | 2026-06-24 | announcement |
| RQ Bio UK | £86M | Series A | 2026-06-24 | announcement |
| Anodyne Nanotech USA | $13M | Series A | 2026-06-24 | announcement |
| Osanni Bio USA | $190M | Series B | 2026-06-23 | announcement |
| Lys Therapeutics France | €25M | Grant | 2026-06-23 | announcement |
| Rapalogix Health USA | $20M | Series A | 2026-06-23 | announcement |
| Trimtech Therapeutics UK | $14M | Seed | 2026-06-23 | announcement |
| Bionyra Pharma USA | $165M | Series A | 2026-06-22 | announcement |
| Vedana Therapeutics USA | $46M | Series A | 2026-06-22 | announcement |
| Memento Medicines USA | $93M | Series A | 2026-06-19 | announcement |
| Portal Biotechnologies USA | $9M | Undisclosed | 2026-06-19 | announcement |
| Triveni Bio USA | $65M | Series C | 2026-06-17 | announcement |
| Aplagon Finland | €5M | Undisclosed | 2026-06-17 | announcement |
| Rejoni USA | $25M | Undisclosed | 2026-06-16 | announcement |
| Cellares USA | $50M | Series D | 2026-06-15 | announcement |
| Radical Numerics USA | $50M | Seed | 2026-06-15 | announcement |
| Human Continuum USA | $5M | Seed | 2026-06-15 | announcement |
| Beren Therapeutics USA | $300M | Debt | 2026-06-10 | announcement |
| Element Biosciences USA | $175M | Series E | 2026-06-10 | announcement |
| SonoThera USA | $125M | Series B | 2026-06-10 | announcement |
| FesariusTherapeutics USA | $20M | Series A | 2026-06-10 | announcement |
| City Therapeutics USA | $100M | Series B | 2026-06-09 | announcement |
| Rejuvenate Bio USA | $6M | Undisclosed | 2026-06-08 | announcement |
| Ona Therapeutics Spain | $87M | Series B | 2026-06-04 | announcement |
| CereVasc USA | $85M | Series C | 2026-06-04 | announcement |
| Contraline USA | $92M | Series B | 2026-06-03 | announcement |
| Oak Hill Bio USA | $32M | Series A | 2026-06-03 | announcement |
| Ingenix Poland | €13M | Seed | 2026-06-03 | announcement |
| Advanced NanoTherapies USA | $31M | Series B | 2026-06-02 | announcement |
| Tavo Biotherapeutics USA | $17M | Series A | 2026-06-02 | announcement |
| Perceptic UK | $12M | Seed | 2026-06-01 | announcement |
May 2026 · 23 events · $3.4B
| Company | Raised | Round | Announced | Source |
|---|---|---|---|---|
| Secretome Therapeutics USA | $30M | Series A | 2026-05-28 | announcement |
| Triomics USA | $22M | Series B | 2026-05-28 | announcement |
| Solstice USA | $21M | Series A | 2026-05-28 | announcement |
| Psilera USA | $9M | Seed | 2026-05-28 | announcement |
| Protuoso Biosciences USA | $10M | Seed | 2026-05-27 | announcement |
| Mykor UK | £4M | Undisclosed | 2026-05-27 | announcement |
| Oorja Bio USA | $30M | Series A | 2026-05-20 | announcement |
| Blank Bio USA | $7M | Seed | 2026-05-20 | announcement |
| Brami USA | $33M | Series B | 2026-05-19 | announcement |
| Create Medicines USA | $122M | Series B | 2026-05-14 | announcement |
| Forus USA | $160M | Undisclosed | 2026-05-13 | announcement |
| Isomorphic Labs UK | $2.1B | Series B | 2026-05-12 | announcement |
| Infex Therapeutics UK | £4M | Undisclosed | 2026-05-12 | announcement |
| Algorithmiq Italy | €18M | Undisclosed | 2026-05-11 | announcement |
| Anagram Therapeutics USA | $250M | Undisclosed | 2026-05-07 | announcement |
| LTZ Therapeutics USA | $38M | Undisclosed | 2026-05-07 | announcement |
| ParcelBio USA | $13M | Seed | 2026-05-07 | announcement |
| CellCentric UK | $220M | Series D | 2026-05-06 | announcement |
| Kanvas Biosciences USA | $48M | Series A | 2026-05-06 | announcement |
| Signadori Bio France | €11M | Seed | 2026-05-06 | announcement |
| Windward Bio Switzerland | $165M | Undisclosed | 2026-05-05 | announcement |
| Cytospire Therapeutics UK | £61M | Series A | 2026-05-05 | announcement |
| mbiomics Germany | $12M | Series A | 2026-05-04 | announcement |
April 2026 · 29 events · $1.8B
| Company | Raised | Round | Announced | Source |
|---|---|---|---|---|
| Moleculent Sweden | $20M | Undisclosed | 2026-04-30 | announcement |
| BioOrbit UK | £10M | Seed | 2026-04-30 | announcement |
| Vivacta Bio USA | $50M | Series A | 2026-04-29 | announcement |
| Coultreon Biopharma Belgium | $125M | Series A | 2026-04-28 | announcement |
| Lighthouse Pharmaceuticals USA | $12M | Series A | 2026-04-28 | announcement |
| Nervonik USA | $52M | Series B | 2026-04-27 | announcement |
| Fathom Therapeutics USA | $47M | Series A | 2026-04-27 | announcement |
| LighthouseAI USA | $8M | Series A | 2026-04-27 | announcement |
| Ray Therapeutics USA | $125M | Series B | 2026-04-21 | announcement |
| Tortugas Neuroscience USA | $106M | Series A | 2026-04-21 | announcement |
| Orthogon Therapeutics USA | $11M | Undisclosed | 2026-04-17 | announcement |
| Beeline Medicines USA | $300M | Series A | 2026-04-16 | announcement |
| STORM Therapeutics USA | $56M | Series C | 2026-04-16 | announcement |
| Alloy Therapeutics USA | $40M | Series E | 2026-04-16 | announcement |
| Terremoto Biosciences USA | $108M | Series C | 2026-04-15 | announcement |
| Adcendo Denmark | $75M | Series C | 2026-04-14 | announcement |
| Spiral Therapeutics USA | $27M | Series B | 2026-04-14 | announcement |
| Helical UK | $10M | Seed | 2026-04-14 | announcement |
| Clean Food Group UK | £4M | Grant | 2026-04-14 | announcement |
| Vivatides Therapeutics USA | $54M | Series A | 2026-04-13 | announcement |
| Sparian Biosciences USA | $15M | Grant | 2026-04-13 | announcement |
| Sidewinder Therapeutics USA | $137M | Series B | 2026-04-09 | announcement |
| Click Therapeutics USA | $50M | Series D | 2026-04-09 | announcement |
| Life Biosciences USA | $80M | Series D | 2026-04-08 | announcement |
| ReAlta Life Sciences USA | $40M | Undisclosed | 2026-04-08 | announcement |
| SpectronRx USA | $85M | Undisclosed | 2026-04-07 | announcement |
| HexemBio USA | $10M | Seed | 2026-04-07 | announcement |
| Stipple Bio USA | $100M | Series A | 2026-04-06 | announcement |
| Generare France | €20M | Series A | 2026-04-05 | announcement |
March 2026 · 25 events · $1.0B
February 2026 · 20 events · $879M
| Company | Raised | Round | Announced | Source |
|---|---|---|---|---|
| EMED Technologies' Subsidiary USA | $8M | Undisclosed | 2026-02-25 | announcement |
| Slate Medicines USA | $130M | Series A | 2026-02-24 | announcement |
| Turbine Hungary | $25M | Series B | 2026-02-24 | announcement |
| Centauri Therapeutics UK | £6M | Series A | 2026-02-24 | announcement |
| Altesa BioSciences USA | $75M | Series B | 2026-02-19 | announcement |
| Korsana Biosciences USA | $175M | Series A | 2026-02-18 | announcement |
| Pharmacelera Spain | €6M | Undisclosed | 2026-02-18 | announcement |
| GelMEDIX USA | $13M | Seed | 2026-02-17 | announcement |
| Tozaro UK | £6M | Undisclosed | 2026-02-16 | announcement |
| The Biological Computing Co. USA | $25M | Seed | 2026-02-12 | announcement |
| ILiAD Biotechnologies USA | $115M | Series B | 2026-02-11 | announcement |
| Loyal USA | $100M | Series C | 2026-02-11 | announcement |
| Atlas Oncology Partners USA | $28M | Series A | 2026-02-11 | announcement |
| 4Moving France | €12M | Grant | 2026-02-10 | announcement |
| Aerska Ireland | $39M | Series A | 2026-02-09 | announcement |
| Phylo USA | $14M | Seed | 2026-02-09 | announcement |
| Third Arc Bio USA | $52M | Series A | 2026-02-04 | announcement |
| SonoVascular USA | $6M | Series A | 2026-02-04 | announcement |
| Prenosis USA | $20M | Series A | 2026-02-02 | announcement |
| PranaX USA | $17M | Series A | 2026-02-02 | announcement |
January 2026 · 45 events · $3.9B
| Company | Raised | Round | Announced | Source |
|---|---|---|---|---|
| Primmune Therapeutics USA | $9M | Series B | 2026-01-30 | announcement |
| Tenpoint Therapeutics UK | $235M | Series B | 2026-01-29 | announcement |
| Breakthru Medicine USA | $60M | Series A | 2026-01-29 | announcement |
| Cellares USA | $257M | Series D | 2026-01-28 | announcement |
| CraniUS Therapeutics USA | $20M | Series B | 2026-01-28 | announcement |
| Elysium Therapeutics USA | $8M | Undisclosed | 2026-01-28 | announcement |
| TRexBio USA | $50M | Undisclosed | 2026-01-27 | announcement |
| Antheia USA | $24M | Series C | 2026-01-27 | announcement |
| Fortitude Biomedicines USA | $13M | Seed | 2026-01-27 | announcement |
| Corxel Pharmaceuticals USA | $287M | Undisclosed | 2026-01-26 | announcement |
| PAQ Therapeutics USA | $77M | Series B | 2026-01-26 | announcement |
| Barnwell Bio USA | $6M | Seed | 2026-01-26 | announcement |
| Mendra USA | $82M | Series A | 2026-01-23 | announcement |
| ErVimmune France | €17M | Series A | 2026-01-21 | announcement |
| Infinitopes UK | $15M | Seed | 2026-01-21 | announcement |
| Exciva Germany | €51M | Series B | 2026-01-20 | announcement |
| Think Bioscience USA | $55M | Series A | 2026-01-20 | announcement |
| Mirador USA | $250M | Series B | 2026-01-13 | announcement |
| Proxima USA | $80M | Seed | 2026-01-13 | announcement |
| Juvena Therapeutics USA | $34M | Series B | 2026-01-13 | announcement |
| Converge Bio USA | $25M | Series A | 2026-01-13 | announcement |
| RISA Labs USA | $11M | Series A | 2026-01-13 | announcement |
| Enspire DBS Therapy USA | $10M | Undisclosed | 2026-01-13 | announcement |
| Orca Bio USA | $250M | Undisclosed | 2026-01-12 | announcement |
| AirNexis Therapeutics USA | $200M | Series A | 2026-01-12 | announcement |
| MEDIPOST USA | $140M | Undisclosed | 2026-01-12 | announcement |
| Kinaset Therapeutics USA | $103M | Series B | 2026-01-12 | announcement |
| Vibrant Therapeutics USA | $61M | Undisclosed | 2026-01-12 | announcement |
| Cytotheryx USA | $60M | Series A | 2026-01-12 | announcement |
| bit.bio UK | $50M | Undisclosed | 2026-01-12 | announcement |
| VieCure USA | $43M | Undisclosed | 2026-01-12 | announcement |
| Avenue Biosciences USA | $6M | Seed | 2026-01-12 | announcement |
| Diagonal Therapeutics USA | $125M | Series B | 2026-01-09 | announcement |
| Parabilis Medicines USA | $305M | Series F | 2026-01-08 | announcement |
| Soley Therapeutics USA | $200M | Series C | 2026-01-08 | announcement |
| Alveus Therapeutics USA | $160M | Series A | 2026-01-08 | announcement |
| EpiBiologics USA | $107M | Series B | 2026-01-08 | announcement |
| Poplar Therapeutics USA | $50M | Series A | 2026-01-08 | announcement |
| Enodia Therapeutics France | €21M | Seed | 2026-01-08 | announcement |
| TECregen Switzerland | $10M | Seed | 2026-01-08 | announcement |
| Rakuten Medical USA | $100M | Series F | 2026-01-07 | announcement |
| Corsera Health USA | $80M | Series A | 2026-01-07 | announcement |
| Mediar Therapeutics USA | $76M | Series B | 2026-01-07 | announcement |
| STRM.BIO USA | $8M | Seed | 2026-01-07 | announcement |
| Vyriad USA | $25M | Series B | 2026-01-02 | announcement |